drugset / Trial / NCT05796973
Measuring Oncological Value of Exercise and Statin
Phase 3
Recruiting
240 enrolled
Tampere University Hospital
Aalto University · collabTampere University · collabUniversity of Helsinki · collabUniversity of Turku · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of the study is to find out whether supervised physical exercise during cancer drug treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian and prostate cancer compared to unsupervised exercise. In addition, the investigators are investigating whether the use of atorvastatin combined with guided group exercise training would further improve the response to cancer treatment.
Timeline
- Start
- 2023-03-31
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |